US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Seizures - Pipeline Review, H1 2016
2/24/2016 | published by: Global Markets Direct
... for Seizures, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Down Syndrome - Pipeline Review, H1 2016
2/24/2016 | published by: Global Markets Direct
... therapeutics under development for Down Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Alcohol Addiction - Pipeline Review, H1 2016
2/29/2016 | published by: Global Markets Direct
... therapeutics under development for Alcohol Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2016
3/22/2016 | published by: Global Markets Direct
... pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...  |  read more...
USD 2,000
Investigation Report on China Fluoxetine Market, 2010-2019
2/29/2016 | published by: China Research and Intelligence Co., Ltd.
... world is up to 1 million people and the amount of depression patients in China has reached 90 million. At present, the recognition rate of depression in our country is only 30% and the identified ...  |  read more...
USD 2,000
Dementia - Pipeline Review, H1 2016
2/29/2016 | published by: Global Markets Direct
... for Dementia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Virtual Reality in Healthcare Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
2/25/2016 | published by: Occams Business Research & Consultancy
... from the real world or may be from an imagined world. It has generated tremendous excitement in the healthcare industry where the applications of virtual reality technology extend to psychiatric, training, medical practice, and among ...  |  read more...
USD 3,900
Global Depression Therapy & Treatment Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
2/25/2016 | published by: Occams Business Research & Consultancy
... market segment. Antidepressants are the most popular treatment methods. Every year more than five billion prescriptions are written globally. Antidepressants segment consists of big pharmaceuticals companies like Eli Lily, Pfizer, GlaxoSmithKline and Forest Laboratories. All ...  |  read more...
USD 3,900
Stem Cell Technologies and Applications Market Report 2016-2026
2/12/2016 | published by: Visiongain
... Avoid struggles to gain that business data. Instead find the best places for expanding revenues, also understanding trends, technologies, therapies and opportunities. Visiongain’s new investigation gives you revenue forecasts to 2026 for the world stem ...  |  read more...
USD 2,519
Narcolepsy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... objective of the Narcolepsy Report is to understand the market and pipeline status of the drugs around the Narcolepsy to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ...  |  read more...
USD 2,000
Global and Chinese Bobath Tables Industry, 2016 Market Research Report
1/20/2016 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Bobath Tables manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides ...  |  read more...
USD 2,900
Global and Chinese Milnacipran Industry, 2016 Market Research Report
1/20/2016 | published by: Prof-Research
... report provides key statistics on the market status of the Milnacipran manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview ...  |  read more...
USD 2,900
Brain Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... diseases in the developed world. While primary brain tumors are relatively rare, the chances of survival for patients with the disease are very low, even with the best treatment options currently available. There are today ...  |  read more...
USD 6,750
Brain Cancer Drug Pathway Analyzer
2/1/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 232 drug targets that are included in this drug-pathway analyzing tool. No less than 229 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Target Atlas in Brain Cancer: A Competitive Outlook
2/1/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. Target Atlas in Brain Cancer: A Competitive Outlook is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Age Related Memory Impairment-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Anorexia Nervosa-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Ataxia-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Bipolar Disorder (Manic Depression)-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Brain Cancer-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Brain Hemorrhage-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Brain Ischemia-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Cognitive Impairment Associated With Schizophrenia (CIAS)-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, ...  |  read more...
USD 1,250
Delirium-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Diabetic Peripheral Neuropathy-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
3  4  5  6    8    10  11  12